Skip to main content

To view all of Dr. Perou’s publications visit: PubMed

https://unclineberger.org/peroulab/wp-login.php?action=logout&_wpnonce=1f2b744d62

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Kimberly H. Allison, MD, Et al. Estrogen and Progesterone Recptor Testing in Breast Cancer: ASCO/CAP Guideline Update Journal of Clinical Oncology 2020 .pdf
Arran K. Turnbull, Et al. Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches BMC Bioinformatics 2020 .pdf
Francesco Schettini, Et al. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis ELSEVIER 2020 .pdf
Shankha Satpathy, Et al. Microscaled proteogenomic methods for precision oncology Nature Communications 2020 .pdf
Meichen Dong, Et al. SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references Oxford 2020 .pdf
Sara R. Selitsky, Et al. Virus expression detection reveals RNAsequencing contamination in TCGA BMC Genomics 2020 .pdf
Arian Lundberg, Et al. A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels Springer Nature 2020 .pdf
Susana Garcia-Recio, Et al. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease The Journal of Clinical Investigation 2020 .pdf
Arjun Bhattacharya, Et al. A framework for transcriptome-wide association studies in breast cancer in diverse study populations Genome Biology 2020 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Halei C. Benefield, Et al. Borderline estrogen receptor-positive breast cancers in black and white women Journal of the National Cancer Institute 2019 .pdf
Emma H. Allott, Et al. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications Breast Cancer Research and Treatment 2019 .pdf
Emma H. Allott, Et al. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium Springer Nature 2019 .pdf
Pooja Middha Kapoor, Et al. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium International Journal of Epidemiology 2019 .pdf
Lisle E Mose, Charles M Perou, and Joel S Parker Improved indel detection in DNA and RNA via realignment with ABRA2 Bioinformatics 2019 .pdf
Kin Yau Wong, Et al. I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms Genome Biology 2019 .pdf
Mohammad A. Alzubi, Et al. Separation of breast cancer and organ microenvironment transcriptomes in metastases Breast Cancer Research 2019 .pdf
Arian Lundberg, Et al. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours Breast Cancer Research 2019 .pdf
Lindsay A. Williams, Et al. Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas Cancer Causes & Control 2019 .pdf
Anonymous Authors Task-Driven Deep Canonical Correlation Analysis Under review 2019 .pdf
Daniel P. Hollern, Et al. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer Cell 2019 .pdf
Lindsay A. Williams, Katherine A. Hoadley, Et al. Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas Springer Nature 2019 .pdf
Arian Lundberg, Et al. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours Breast Cancer Research 2019 .pdf
Youli Xia, Cheng Fan, Et al. Genetic determinants of the molecular portraits of epithelial cancers Nature Communications 2019 .pdf
Anonymous Authors Task-Driven Canonical Correlation Analysis Anonymous Institution 2019 .pdf
Adrienne G. Waks, Et al. The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy AACR Publications 2019 .pdf
Yao Jiang, Et al. MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression Nature Communications 2019 .pdf
Adam D. Pfefferle, Et al. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor The Company of Biologists 2019 .pdf
Mohammad A. Alzubi, Et al. Separation of breast cancer and organ microenvironment transcriptomes in metastases Breast Cancer Research 2019 .pdf
Glada Zurlo, Et al. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer Nature Communications 2019 .pdf
A.C. Picornell, Et al. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series BMC Genomics 2019 .pdf
S. J. Kim, Et al. Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression  Springer Nature 2019 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Julija Hmeljak, Et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma Cancer Discovery 2018 PubMed
Maki Tanioka, Et al. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer Genome Medicine 2018 .pdf
Daniel P. Hollern, Et al. A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer Breast Cancer Research and Treatment 2018 .pdf
Yeji An, Et al. Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast Cell Reports 2018 PubMed
Xiang Shu, Et al. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis International Journal of Epidemiology 2018 .pdf
Heather D. Couture, et al. Multiple Instance Learning for Heterogeneous Images: Training a CNN for Histopathology International Conference on Medical Image Computing and Computer-Assisted Intervention 2018 .pdf
Heather D. Couture, Et al. Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype Nature 2018 .pdf
Jonathan T. Lei, Et al. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer Cell Reports 2018 .pdf
Rajshekhar R. Giraddi, Et al. Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development Cell Reports 2018 .pdf
Tuan M. Nguyen, Et al. FGFR1-activated Translation of WNT Pathway Components with Structured 5′ UTRs is Vulnerable to Inhibition of EIF4A-dependent Translation Initiation AACR Publications 2018 .pdf
Priyanka Sharma, Et al. Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel AACR Publications 2018 .pdf
Maki Tanioka, Et al. Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzmab-Based Neoadjuvant Chemotherpy in HER2-Positive Breast Cancer AACR Publications 2018  .pdf
Jing Zhang, Et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma Science 2018 .pdf
Neelam V. Desai, Et al. Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay Breast Cancer Research 2018 .pdf
Lindsay A. Williams, Et al. TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases” Nature 2018 .pdf
Hui Shen, Et al. Integrated Molecular Characterization of Testicular Germ Cell Tumors Cell Reports 2018 PubMed
Juan Miguel Cejalvo, Et al. Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer ELSEVIER 2018 .pdf
Andrew Tutt, Et al. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial Nature Medicine 2018 .pdf
Samantha Puvanesrajah, Et al. PAM50 and risk of recurrence scores for interval breast cancers Cancer Prevention Research 2018 .pdf
Katherine A. Hoadley, Et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Cell 2018 PubMed
Isabel Echavarria, Et al. Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann’s Refined Classification Clinical Cancer Research 2018 .pdf
Motoki Takaku, Et al. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network Nature Communications 2018 .pdf
Alexandra Thomas, Et al. Tumor mutational burden is a determinant of immune-mediated survival in breast cancer OncoImmunology 2018 PubMed
Marni B. Siegel, Et al. Integrated RNA and DNA Sequencing Reveals Early Drivers of Metastatic Breast Cancer The Journal of Clinical Investigation 2018 .pdf
Wei Sun, Et al. The association between copy number aberration, DNA methylation and gene expression in tumor samples Nucleic Acids Research 2018 .pdf
Marni B. Siegel, Et al. Integrated RNA and DNA sequencing reveals early
drivers of metastatic breast cancer
2018 .pdf
Simon R. V. Knott, Et al. Asparagine bioavailability governs metastasis in a model of breast cancer Nature 2018 .pdf
Milan Radovich, Et al. The Integrated Genomic Landscape of Thymic
Epithelial Tumors
Cancer Cell 2018 PubMed
Emma H. Allott, Et al. Frequency of breast cancer subtypes among African American women in the AMBER consortium Breast Cancer Research 2018 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Emma Nolan, Et al. Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancerr Science Translational Medicine 2017 .pdf
Juan M. Cejalvo, Et al. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer Cancer Research 2017 .pdf
Dezheng Huo, Et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in the Cancer Genome Atlas JAMA Oncology 2017 .pdf
Hawazin Faruki, Et al. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape JTO 2017 .pdf
Jon S. Zawistowski, Et al. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition is Attenuated by Pharmacologic Targeting of the P-TEFb Complex Cancer Discovery 2017 .pdf
K Roarty, Et al. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression Nature 2017 .pdf
Kuan-lin Huang, Et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts Nature Communications 2017 .pdf
Charles Bowerman, Et al. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer Nano Letters 2017 .pdf
Paola A. Rojas, Et al. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness JNCI 2017 .pdf
Jacquelyn J. Bower, Et al. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells NPJ 2017 .pdf
Gaurav A. Mehta, Et al. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer Breast Cancer Research Treatment 2017 .pdf
Daniel Kechele, Et al. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation Journal of Clinical Investigation 2017 .pdf
Grace O. Silva, Et al. SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling Genome Biology 2017
.pdf
The Cancer Genome Atlas Research Network Integrated genomic and molecular characterization of cervical cancer Genome Biology 2017
.pdf
Farshad Farshidfar, Et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles Genome Biology 2017
.pdf
The Cancer Genome Atlas Research Network Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Cell 2017
.pdf
Lauren Fishbein, Et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Cancer Cell 2017
.pdf
Andrew D. Cherniack, Et al. Integrated Molecular Characterization of Uterine Carcinosarcoma Cancer Cell 2017
.pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Philipp Mertins, Et al. Proteogenomics connects somatic
mutations to signalling in breast cancer
Macmillan Publishers Limited 2016 .pdf
Haikuo Zhang, Et al. Oncogenic Deregulation of EZH2 as an
Opportunity for Targeted Therapy in
Lung Cancer
American Association for Cancer Research 2016 .pdf
Michael D. Iglesia, Et al. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types Oxford 2016 .pdf
Zhijian He, Et al. A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity Elsevier 2016 .pdf
Jennifer B. Dennison, Et al. High intra-tumoral stromal content defines Reactive breast cancer as a low-risk breast cancer subtype American Association for Cancer Research 2016 .pdf
Wei Zhao, Et al. Identification of mRNA isoform switching in breast cancer BMC Genomics 2016 .pdf
Michele Ceccarelli, Et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma CellPress 2016 .pdf
Joshua D Campbell, Et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas Nature Genetics 2016 .pdf
Adam D. Pfefferle, Et al. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers The Company of Biologists 2016 .pdf
Minetta C. Liu, Et al. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy:correlative analysis of C9741 (Alliance) npj Breast Cancer 2016 .pdf
Emma H. Allott, Et al. Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium Cancer, Epidemiology, Biomarkers & Prevention 2016 .pdf
Priyanka Sharma1, Et al. Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts AACR Publications 2016 .pdf
Jerry Usary, David Darr, Adam Pfefferle and Charles Perou Overview of Genetically Engineered UNIT 14.38 Mouse Models of Distinct Breast Cancer Subtypes Current Protocols in Pharmacology 2016 .pdf
Michael Iglesia, Et al. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types JNCI 2016 .pdf
Marc A. Becker, Et al. Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer PLOS One 2016 .pdf
George W. Sledge, Anees Chagpar and Charles Perou Collective Wisdom: Lobular Carcinoma of the Breast ASCO 2016 .pdf
Hui Li, Et al. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays Breast Imaging 2016 .pdf
Hui Li, Et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set npj Breast Cancer 2016 .pdf
Edith A. Perez, Et al. Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG
(Alliance) N9831 Trial
JNCI 2016 .pdf
Miguel Martin, Et al. Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in nodepositive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study Breast Cancer Res. Treat. 2016 .pdf
Campbell D. Lawson, Et al. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-activating
Proteins in Basal-like Breast Cancers
AACR 2016 .pdf
Yujing J. Heng, Et al. The molecular basis of breast cancer pathological phenotypes Pathology 2016 .pdf
Melissa A. Troester, Et al. DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas npj Breast Cancer 2016 .pdf
Cancer Genome Atlas Research Network Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma NEJM 2016 .pdf
Lisle E. Mose, Et al. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with
V’DJer
Bioinformatics Advance Access 2016 .pdf
Aleix Prat, Et al. A PAM50-Based Chemoendocrine Score for HormoneReceptor–Positive Breast Cancer with an
Intermediate Risk of Relapse
Clinical Cancer Research 2016 .pdf
Denise K. Reaves, Et al. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis Molecular Cancer Research 2016 .pdf
Katherine A. Hoadley, Et al. NTumor Evolution in Two Patients with Basallike Breast Cancer: A Retrospective Genomics Study of Multiple Metastases PLOS 2016 .pdf
Charles J. Bowerman, Et al. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer Nano Letters 2016
.pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Justin L. Black, Et al. CIB1 depletion impairs cell survival and tumor growth
in triple-negative breast cancer
Breast Cancer Res. Treat. 2015 .pdf
J Knezevic, Et al. Expression of miR-200c in claudin-low breast cancer alters
stem cell functionality, enhances chemosensitivity and reduces
metastatic potential
Oncogene advance online publication 2015 .pdf
Ze-Yi Zheng, Et al. Wild-Type N-Ras, Overexpressed in Basal-likeBreast Cancer, Promotes Tumor Formation by
Inducing IL-8 Secretion via JAK2 Activation
Cell Reports 2015 .pdf
Pu Wang, Et al. Oncometabolite D-2-Hydroxyglutarate Inhibits
ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents
Cell Reports 2015 .pdf
Christian D. Young, Et al. Activating PIK3CA mutations induce an EGFR/ERK paracrine signaling axis in basal-like
breast cancer
MCP Papers in Press 2015 .pdf
Hisham Mohammed, Et al. Progesterone receptor modulates ERa action in breast cancer Nature 2015 .pdf
Kelly V. Ruggles, Et al. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer MCP Papers in Press 2015 .pdf
Christopher Dravis, Et al. Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells Cell Reports 2015 .pdf
Giovanni Ciriello, Et al. Comprehensive Molecular Portraits of Invasive
Lobular Breast Cancer
Cell 2015 .pdf
The Cancer Genome Atlas Network Genomic Classification of Cutaneous Melanoma Cell 2015 .pdf
The Cancer Genome Atlas Research
Network
The Molecular Taxonomy of Primary Prostate Cancer Cell 2015 .pdf
Michael A. Cantrell, Et al. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression Impact Journals 2015 .pdf
J Knezevic1, Et al. Expression of miR-200c in claudin-low breast cancer alters
stem cell functionality, enhances chemosensitivity and reduces metastatic potential
Oncogene advance online publication 2015 .pdf
Christian D. Young, Et al. Activating PIK3CA mutations induce an EGFR/ERK paracrine signaling axis in basal-like breast cancer MCP Papers in Press 2015 .pdf
Joshua D Welch, Et al. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential BMC Genomics 2015 .pdf
Elvin Wagenblast, Et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis Macmillan Publishers 2015 .pdf
William T. Barry, Et al. The Use of Bayesian Hierarchical Models for Adaptive Randomization in Biomarker-Driven Phase II Studies Journal of Biopharmaceutical Statistics 2015 .pdf
William F. Anderson, Et al. Response JNCI 2015 .pdf
Torsten O. Nielsen and Charles M. Perou CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping AACR 2015 .pdf
Adam D. Pfefferle, Et al. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy Breast Cancer Res Treat 2015 .pdf
Mei Zhang, Et al. Intratumoral heterogeneity in a p53 null mouse model of human breast cancer Cancer Discovery 2015 .pdf
Zhijian He, Et al. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: Preparation, in vitro and in vivo evaluation Journal of Controlled Release 2015 .pdf
Maggie C.U. Cheang, Et al. Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression The Oncologist 2015 .pdf
The Cancer Genome Atlas Network Comprehensive genomic characterization of head and neck squamous cell carcinomas Nature 2015 .pdf
Yi-Juan Hu, Et al. Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data Journal of the American Statistical Association 2015 .pdf
Ligibel, Jennifer A., Et al. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) JNCI 2015 .pdf
Carey, Lisa A., Et al. Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib Journal of Clinical Oncology 2015 .pdf
Silva, Grace O., Et al. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer Breast Cancer Research Treatment 2015 .pdf
Voduc, K. David, Et al. αB-crystallin expression in breast cancer is associated with brain metastasis Nature 2015 .pdf
Allott, Emma H., Et al. Performance of Three Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium CEBP 2015 .pdf
Faruki, Hawazin, Et al. Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded
Lung Tumor Gene Expression Data Sets
Archives of Pathology & Laboratory Medicine 2015 .pdf
Prat, Aleix, Et al. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy BMC Medicine 2015 .pdf
Carey, Lisa A. and Perou, Charles M. Palbociclib — Taking Breast-Cancer Cells Out of Gear New England Journal of Medicine 2015 .pdf
Wallden, Brett, Et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay BMC Medical Genomics 2015 .pdf
D’Arcy, Monica, Et al. Race-associated biological differences among Luminal A breast tumors Breast Cancer Research Treatment 2015 .pdf
Towers, Christina G., Et al. The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p Nature Communications 2015 .pdf
The Cancer Genome Atlas Network Comprehensive genomic characterization of head and neck squamous cell carcinomas Nature 2015 .pdf
The Cancer Genome Atlas Network Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas New England Journal of Medicine 2015 .pdf
The Cancer Genome Atlas Network Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma New England Journal of Medicine 2015 .pdf
Parker, Joel S and Perou, Charles M. Tumor Heterogeneity: Focus on the Leaves, the Trees, or the Forest? Cancer Cells 2015 .pdf
Cancer Genome Atlas Network Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma NEJM 2015 .pdf
Cancer Genome Atlas Network Genomic Classification of Cutaneous Melanoma Cell 2015 .pdf
Anne F. Schott, Charles M. Perou and Daniel F. Hayes Genome Medicine in Cancer: What’s in a Name? Cancer Research 2015 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Katherine Drews-Elger, Et al. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures Breast Cancer Res Treat 2014 .pdf
Lin Xiao, Et al. Identification of a stable molecular signature in mammary tumor
endothelial cells that persists in vitro
Angiogenesis 2014 .pdf
Zhou, Et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal The Journal of Clinical Investigation 2014 .pdf
The Cancer Genome Atlas Research Network Comprehensivemolecular characterization of urothelial bladder carcinomar Nature 2014 .pdf
Mose, Lisle E., Et. al. ABRA: improved coding indel detection via assembly based realignment Sequence Analysis 2014 .pdf
Barry, William T., Et. al. A Bayesian Hierarchical Model for Adaptive Biomarker Strategies in Randomized Phase II
Studies
Duke Biostatistics and Bioinformatics (B&B) Working Paper Series 2014 .pdf
Jenkins, Emily O., Et. al. Age-Specific Changes in Intrinsic Breast Cancer Subtypes: A Focus on Older Women Geriatric Oncology 2014 .pdf
Iglesia, Michael D., Et. al. Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer Clinical Cancer Research 2014 .pdf
Bai, Feng, Et. al. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development Cancer Research 2014 .pdf
Prat, Aleix, Et. al. Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation
status
Breast Cancer Research and Treatment 2014 .pdf
Sikov, William M., Et. al. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III
Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
Journal of Clinical Oncology 2014 .pdf
Goetz, Matthew P., Et. al. Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic
Studies
JNCI 2014 .pdf
Anderson, William F., Et. al. How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More? JNCI 2014 .pdf
Zhao, Wei, Et. al. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for
expression profiling
BMC Genomics 2014 .pdf
Tao, Jessica J., Et. al. Antagonism of EGRF and HER3 Enhances the Response to Inhibitors of the P12K-Akt Pathway in Triple-Negative Breast Cancer Science Signaling 2014 .pdf
Prat, Aleix, Et. al. Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer JNCI 2014 .pdf
Gatza, Michael, Et. al. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer Nature Genetics 2014 .pdf
Romero, A., Et. al. Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications
on patient’s management and therapy selection
Clin Transl Oncol 2014 .pdf
Tobin, N.P., Et. al. The Molecular Subtype and Tumor Characteristics of Breast Cancer Metastases Significantly Influence Patient Post-Relapse Survival Annals of Oncology 2014 .pdf
Bockhorn, Jessica, Et. al. Acquired differentiation and loss of malignancy of spontaneous models pulmonary metastases in human-in-mouse breast cancer Cancer Research 2014 .pdf
Nair, R., Et. al. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer Oncogene 2014 .pdf
Song, Gina, Et. al. Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models Clinical Cancer Research 2014 .pdf
Parra-Palau, Josep Lluís, Et. al. Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy JNCI 2014 .pdf
Cortazar, Patricia, Et. al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 2014 .pdf
Kimes, Patrick K., Et. al. SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples Nucleic Acids Research 2014 .pdf
Phillips, Sarah, Et. al. Cell-State Transitions Regulated by SLUG Are Critical for Tissue Regeneration and Tumor Initiation ISSCR 2014 .pdf
Sun, Zhuoxin, Et. al. Chemotherapy Benefit for “ER-Positive” Breast Cancer and Contamination of Non-Luminal Subtypes – Waiting for TAILORx and RxPONDER Annals of Oncology 2014 .pdf
Anders, Carey, Et. al. TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases Breast Cancer Res Treat 2014 .pdf
The Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma Nature 2014 .pdf
Davis, Caleb F., Et. al. The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma Cancer Cell 2014 .pdf
The Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma Nature 2014 .pdf
Hoadley, Katherine A., Et. al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin Cell 2014 .pdf
The Cancer Genome Atlas Research Network Integrated Genomic Characterization of Papillary Thyroid Carcinoma Cell 2014 .pdf
Prat, A., Et. al. Predicting response and survival in chemotherapy-treated triple-negative breast cancer BJC 2014 .pdf
Wilkerson, Matthew D., Et. al. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors Nucleic Acids Research 2014 .pdf
Oh, Daniel S., Et. al. Radiation-Induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Radiation Research 2014 .pdf
Hoadley, Katherine A., Fabrice, Andre, Ellis, Matthew J., Perou, Charles M. Breast cancer intrinsic subtypes Nature 2014 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
R Nair, Et al. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer  Oncogene 2013 .pdf
Miguel Martı´n, Et al. PAM50 proliferation score as a predictor of weekly paclitaxel
benefit in breast cancer
Breast Cancer Research & Treatment 2013 .pdf
Jennifer R Won, Et al. A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard  Modern Pathology 2013 .pdf
ALEIX PRAT, Et al. Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers  The Oncologist 2013 .pdf
Matthew J. Ellis, Et al. The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap Cancer Discovery 2013 .pdf
A. Goldhirsch, Et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Annals of Oncology 2013 .pdf
Jessica Bockhorn, Et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 Nature Communications 2013 .pdf
Brittni A. Smith, Et al. Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes Genes and Cancers 2013 .pdf
Li-Jun Di, Et al. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer Nature Communications 2012 .pdf
David H. Nguyen, Et al. Murine Microenvironment Metaprofiles Associate with Human Cancer Etiology and Intrinsic Subtypes Clinical Cancer Research 2013 .pdf
Christian D. Young, Et al. Conditional Loss of ErbB3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK3CA without Affecting Mammary Tumor Latency, Gene Expression, or Signaling Cancer Research 2013 .pdf
Carey K. Anders, Et al. Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer PLOS One 2013 .pdf
The Cancer Genome Atlas Research Network Integrated genomic characterization of endometrial carcinoma Nature 2013 .pdf
Xiaomei Zhang, Et al. A Renewable Tissue Resource of Phenotypically Stable,  Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models Cancer Research 2013 .pdf
 Jerry Usary, Et al. Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice Clinical Cancer Research 2013 .pdf
Kristy L. Richards, Et al. Gene Profiling of Canine B-Cell Lymphoma Reveals Germinal Center and Postgerminal Center Subtypes with Different Survival Times, Modeling Human DLBCL Cancer Research 2013 .pdf
Matthew D. Wilkerson, Et al. Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens The Journal of Molecular Diagnostics 2013 .pdf
The Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 2013 .pdf
A. Romero, Et al. Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient’s management and therapy selection Clin Transl Oncol 2013 .pdf
J. Chuck Harrell, Et al. Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis Clin Exp Metastasis 2013 .pdf
Christopher R. Cabanski, Et al. BlackOPs: increasing confidence in variant detection through mappability filtering Nucleic Acids Research 2013 .pdf
Ken Chen, Et al. BreakTrans: uncovering the genomic architecture of gene fusions Genome Biology 2013 .pdf
Meghan M. Morrison, Et al. ErbB3 downregulation enhances luminal breast tumor response to antiestrogens The Journal of Clinical Investigation 2013 .pdf
Giovanni Ciriello, Et al.  The molecular diversity of Luminal A breast tumors Breast Cancer Research Treatment 2013 .pdf
Shunqiang Li, Et al. Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts Cell Reports 2013 .pdf
Nicole Vincent Jordan, Et al. SWI/SNF Chromatin-Remodeling Factor Smarcd3/Baf60c Controls Epithelial-Mesenchymal Transition by Inducing Wnt5a Signaling Molecular and Cellular Biology 2013 .pdf
Cameron W. Brennan, Et al. The Somatic Genomic Landscape of Glioblastoma Cell 2013 .pdf
Aleix Prat, Et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes Breast Cancer Research Treatment 2013 .pdf
Jennifer R. Won, Et al. A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard Modern Pathology 2013 .pdf
Li-Jun Di, Et al. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming
in breast cancer
Nature Communications 2013 .pdf
Xiao, Lin, Harrell, J. Chuck, Perou, Charles M., Dudley, Andrew C. Identification of a stable molecular signature in mammary tumor endothelial cells that persists in vitro Angiogenesis 2013 .pdf
Sundaram, Sneha, Et al. Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer Breast Cancer Res Treat 2013 .pdf
Brauer, Heather Ann, Et al. Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer Human Cancer Biology 2013 .pdf
Bardowell, Sabrina A., Et al. Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns Breast Cancer Res Treat 2013 .pdf
Pfefferle, Adam D., Et al. Transcriptomic classification of genetically engineered mouse models of breast cancer
identifies human subtype counterparts
Genome Biology 2013 .pdf
Hanker, Ariella B., Et al. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to
combinations of anti-HER2 therapies
PNAS 2013 .pdf
Cancer Genome Atlas Research Network Comprehensivemolecular characterization of clear cell renal cell carcinoma Nature 2013 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Patrick J. Roberts, Et al. Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy JNCI 2012 .pdf
Collaborative Cross Consortium The Genome Architecture of the Collaborative Cross
Mouse Genetic Reference Population
Genetics 2012 .pdf
Maggie C.U. Cheang, Et al. Substitution in the NCIC.CTG MA.5 Randomized Trial
Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline
Critical Cancer Research 2012 .pdf
Chad J. Creighton, Et al. Integrated Analyses of microRNAs Demonstrate Their
Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma
PLOS One 2012 .pdf
James S. Duncan, Et al. Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer Cell 2012 .pdf
A. Prat, Et al. Concordance among gene expression-based predictors
for ER-positive breast cancer treated with adjuvant
tamoxifen
Annals of Oncology 2012 .pdf
Jessica E. Hutti, Et al. Oncogenic PI3K Mutations Lead to NF-kB–Dependent
Cytokine Expression following Growth Factor Deprivation
Cancer Research 2012 .pdf
Matthew D. Wilkerson, Et al. Differential Pathogenesis of Lung Adenocarcinoma
Subtypes Involving Sequence Mutations, Copy Number,
Chromosomal Instability, and Methylation
PLOS One 2012 .pdf
Sarah M. Dunlap, Et al. Dietary Energy Balance Modulates Epithelial – To – Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-Like Mammary Tumor Models Cancer Prev Res 2012 .pdf
Keli Xu, Et al. Lunatic Fringe Deficiency Cooperates with the Met/Caveolin Gene Amplicon to Induce Basal-like Breast Cancer Cancer Cell 2012 .pdf
Laura J. Esserman, Et al. Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657 Journal of Clinical Oncology 2012 .pdf
The Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumors Nature 2012 .pdf
Lisa A. Carey, Et al. TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer JOURNAL OF CLINICAL ONCOLOGY 2012 .pdf
Wenjin Liu, Et al. LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma Cancer Cell 2012 .pdf
Aleix Prat, Et al. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer JOURNAL OF CLINICAL ONCOLOGY 2012 .pdf
A. Prat, Et al. PAM50 assay and the three-gene model for identifying the major
and clinically relevant molecular subtypes of breast cancer
Breast Cancer Research and Treatment 2012 .pdf
Stephen K. Chia, Et al. A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen Clinical Cancer Research 2012 .pdf
The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 2012 .pdf
Marsha D. Wallace, Et al. Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver Genetics 2012 .pdf
Patrick J. Roberts, Et al. Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models Clinical Cancer Research 2012 .pdf
Christopher R Cabanski, Et al. ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data BMC Bioinformatics 2012 .pdf
The Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers Nature 2012 .pdf
Roy RL Bastien, Et al. PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers BMC Medical Genomics 2012 .pdf
Jessica Bockhorn, Et al. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Breast Cancer Research and Treatment 2012 .pdf
Jacob Ulirsch, Et al. Vimentin DNA methylation predicts survival in breast cancer Breast Cancer Research and Treatment 2012 .pdf
Heather Ann Brauer, Et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer Clinical Cancer Research 2012 .pdf
Hann-Hsiang Chao, Et al. Micro-Scale Genomic DNA Copy Number Aberrations as Another Means of Mutagenesis in Breast Cancer PLOS One 2012 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
 J. Terese Camp, Et al. Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers Molecular Cancer Research 2011 .pdf
Cheng Fan, Et al. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures BMC Medical Genomics 2011 .pdf
Stefan Glu¨ck, Et al. TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine – trastuzumab Breast Cancer Research and Treatment 2011 .pdf
Anita K.Dunbier, Et al. Association between breast cancer subtypes and response to neoadjuvant
anastrozole
Steroids 2011 .pdf
M. Martin, Et al. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer Breast Cancer Research and Treatment 2011 .pdf
Atocha Romero, Et al. Assessment of Topoisomerase II Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization The American Journal of Pathology 2011 .pdf
Jason I. Herschkowitz, Et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells PNAS 2011 .pdf
Amy N. Abell, Et al. MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells Cell Stem Cell 2011 .pdf
Zhe Jiang, Et al.  RB1 and p53 at the crossroad of EMT and triple negative breast cancer Cell Cycle 2011 .pdf
Aleix Prat,Charles M. Perou  Deconstructing the molecular portraits of breast cancer Molecular Oncology 2011 .pdf
A. Goldhirsch, Et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer Annals of Oncology 2011 .pdf
J. Chuck Harrell, Et al. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse Breast Cancer Research and Treatment 2011 .pdf
The Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 2011 .pdf
 Patricia J. Keller, Et al. Defining the cellular precursors to human breast cancer PNAS 2011 .pdf
Vessela N. Kristensen, Et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling PNAS 2011 .pdf
James M. Haughian, Et al. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch PNAS 2011 .pdf
Victor J. Weigman, Et al. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival Breast Cancer Research and Treatment 2011 .pdf
Christopher A Haiman, Et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer Nature Genetics 2011 .pdf
Vilde D Haakensen, Et al. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features BMC Medical Genomics 2011 .pdf
 Justin M. Balko, Et al. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium PNAS 2011 .pdf
Laura J. Esserman, Et al. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Breast Cancer Research and Treatment 2011 .pdf
Aleix Prat, Et al. Practical implications of gene-expressionbased assays for breast oncologists Nature Reviews Clinical Oncology 2011 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Jeran K. Stratford, Et al. A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma PLOS Medicine 2010 .pdf
Roel G.W. Verhaak, Et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 2010 .pdf
Anita K. Dunbier, Et al. Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women Journal of Clinical Oncology 2010 .pdf
William J. Irvin, Jr., Et al. Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer Clinical Breast Cancer 2010 .pdf
Houtan Noushmehr, Et al. Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma Cancer Cell 2010 .pdf
Christopher R. Cabanski, Et al. SWISS MADE: Standardized WithIn Class Sum of Squares to Evaluate Methodologies and Dataset Elements PLOS One 2010 .pdf
 Li Ding, Et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft Nature 2010 .pdf
Adam C. Pond, Et al. Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer Cancer Research 2010 .pdf
Chad Deisenroth, Et al. Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53† Molecular and Cellular Biology 2010 .pdf
Zhe Jiang, Et al. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status The Journal of Clinical Investigation 2010 .pdf
Peter Van Loo, Et al. Allele-specific copy number analysis of tumors PNAS 2010 .pdf
Sebastia´n Giulianelli, Et al. MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements Breast Cancer Research and Treatment 2010 .pdf
Carey K. Anders, Et al. The Prognostic Contribution of Clinical Breast Cancer Subtype, Age, and Race Among Patients With Breast Cancer Brain Metastases Cancer 2010 .pdf
Matthew D. Wilkerson, Et al. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types Clinical Cancer Research 2010 .pdf
Aaron R. Thorner, Et al. Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer PLOS One 2010 .pdf
Torsten O. Nielsen, Et al. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer Clinical Cancer Research 2010 .pdf
Katie M. O’Brien, Et al. Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study Clinical Cancer Research 2010 .pdf
Charles M. Perou and Anne-Lise Børresen-Dale Systems Biology and Genomics of Breast Cancer Cold Spring Harbor Perspective 2010 .pdf
Charles M. Perou Molecular Stratification of Triple-Negative Breast Cancers The Oncologist 2010 .pdf
Aleix M. Prat, Et. al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Research 2010
.pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
ANDREY A. SHABALIN, Et al. Finding Large Average Submatrices in High Dimensional Data The Annals of Applied Statistics 2009 .pdf
Judith Hugh, Et al. Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial Journal of Clinical Oncology 2009 .pdf
Joel S. Parker, Et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes Journal of Clinical Oncology 2009 .pdf
Xin-Hai Pei, Et al. CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis Cancer Cell 2009 .pdf
Zhiyuan Hu, Et al. A compact VEGF signature associated with distant metastases and poor outcomes BMC Medicine 2009 .pdf
Shuying Liu, Et al. Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases Cancer Cell 2009 .pdf
Robert J. Crowder, Et al. PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer Cancer Research 2009 .pdf
Andrea H Bild, Et al. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer Breast Cancer Research 2009 .pdf
Bryan T. Hennessy, Et al. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics Cancer Research 2009 .pdf
Maggie C. U. Cheang, Et al. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer Journal of the National Cancer Institute 2009 .pdf
Wei Sun, Et al. Integrated study of copy number states and genotype calls using high-density SNP arrays Nucleic Acids Research 2009 .pdf
Chad J. Creighton, Et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proceedings of the National Academy of the Sciences of the USA 2009 .pdf
Andrew Courtwright, Et al. Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway Cancer Research 2009 .pdf
Theresa A. DiMeo, Et al. A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer Cancer Research 2009 .pdf
Aleix Prat & Charles M Perou Mammary development meets cancer genomics Nature Medicine 2009 .pdf
Sanjay Chandriani, Et al. A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response PLOS One 2009 .pdf
Dezheng Huo, Et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer Journal of Clinical Oncology 2009 .pdf
Melissa A. Troester, Et al. Microarrays and Epidemiology: Ensuring the Impact and Accessibility of Research Findings Cancer Epidemiology, Biomarkers & Prevention 2009 .pdf
Melissa A. Troester, Et al. Activation of Host Wound Responses in Breast Cancer Microenvironment Clinical Cancer Research 2009 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Roy Bastien, Et al. High-Throughput Amplicon Scanning of the TP53 Gene in Breast Cancer Using High-Resolution Fluorescent Melting Curve Analyses and Automatic
Mutation Calling
Human Mutation 2008 .pdf
D. Craig Allred, Et al. Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution Clinical Cancer Research 2008 .pdf
W. F. Anderson, Et al. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program Breast Cancer Research and Treatment 2008 .pdf
Maggie C.U. Cheang, et al. Basal-LikeBreastCancer Definedby Five Biomarkers Has Superior Prognostic Value thanTriple-Negative Phenotype Clinical Cancer Research 2008 .pdf
Andrey A. Shabalin, Et al. Merging two gene-expression studies via cross-platform normalization Bioinformatics 2008 .pdf
Mollie H Wright, Et al. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1 Molecular Cancer 2008 .pdf
Rajendra Bhati, Et al. Molecular Characterization of Human Breast Tumor Vascular Cells The American Journal of Pathology 2008 .pdf
Lindsay A Brown, Et al. ESR1 gene amplification in breast cancer: a common phenomenon? Nature Genetics 2008 .pdf
Patricia V. Basta, Et al. Genetic variation in Transaldolase1 and risk of squamous cell carcinoma of the head and neck Cancer Detection and Prevention 2008 .pdf
Jason I Herschkowitz, Et al. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas Breast Cancer Research 2008 .pdf
PK Julka, Et al. A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling British Journal of Cancer 2008 .pdf
The Cancer Genome Atlas Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 2008 .pdf
AR Thorner, Et al. In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 2008 .pdf
Bryan P. Schneider, Et al. Triple-Negative Breast Cancer: Risk Factors to PotentialTargets Clinical Cancer Research 2008 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Stephen J Chanock, Et al. Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas Breast Cancer Research 2007 .pdf
Shannon K Penland, Et al. RNA expression analysis of formalin-fixed paraffin-embedded tumors Laboratory Investigation 2007 .pdf
Lisa A. Carey, Et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Clinical Cancer Research 2007 .pdf
Montserrat Garcia-Closas, Et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer International Journal of Cancer 2007 .pdf
Jason I Herschkowitz, Et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biology 2007 .pdf
Michael Mullins, Et al. Agreement in Breast Cancer Classification between Microarray and Quantitative Reverse Transcription PCR from Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Tissues Clinical Chemistry 2007 .pdf
Robert C. Millikan, Et al. Epidemiology of basal-like breast cancer Breast Cancer Research and Treatment 2007 .pdf
Mark F. Burkart, Et al. Clustering Microarray-Derived Gene Lists Through Implicit Literature Relationships Bioinformatics 2007 .pdf
SJ Bultman, Et al. Characterization of mammary tumors from Brg1 heterozygous mice Oncogene 2007 .pdf
Jian Jiang, Et al. Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis Propeomics Clinical Applications 2007 .pdf
Katherine A Hoadley, Et al. EGFR associated expression profiles vary with breast tumor subtype BMC Genomics 2007 .pdf
Sunil Badve, Et al. FOXA1Expression in Breast CancerCorrelationwith Luminal
SubtypeA and Survival
Clinical Cancer Research 2007 .pdf
Montserrat Garcia-Closas, Et al. Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor A Tumor Status Cancer Epidemiology Biomarkers and Prevention 2007 .pdf
Chad A. Livasy MD, Et al. Identification of a basal-like subtype of breast ductal carcinoma in situ Human Pathology 2007 .pdf
Zhe Li, Et al. ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 Complex Cancer Cell 2007 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Jose V. Moyano, Et al. B-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer The Journal of Clinical Investigations 2006 .pdf
Michael L. Whitfield, Et al. Common markers of proliferation Nature Reviews Cancer 2006 .pdf
V Ciocca, Et al. Cytokeratin profiles of male breast cancers Histopathology 2006 .pdf
Daniel S. Oh, Et al. Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers Journal of Clinical Oncology 2006 .pdf
Laurent Perreard, Et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Research 2006 .pdf
Zhiyuan Hu, Et al. The molecular portraits of breast tumors are conserved across
microarray platforms
BMC Genomics 2006 .pdf
Lisa A. Carey, Et al. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study JAMA 2006 .pdf
Cheng Fan, Et al. Concordance among Gene-Expression–Based Predictors for Breast Cancer MEJM 2006 .pdf
Gro Leite Størvold, Et al. siRNA: A Potential Tool for Future Breast Cancer Therapy? Critical Reviews in Oncogenesis 2006 .pdf
Therese Sørlie, Et al. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer Molecular Cancer Therapeutics 2006 .pdf
D. Neil Hayes, Et al. Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts Journal of Clinical Oncology 2006 .pdf
Melissa A Troester, Et al. Gene expression patterns associated with p53 status in breast cancer BMC Cancer 2006 .pdf
David S. Shames, Et al. A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies PLOS Medicine 2006 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Zhiyuan Hu, Et al. High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays Biotechniques 2005 .pdf
Members of the Toxicogemoics Research Consortium Standardizing global gene expression analysis between laboratories and across platforms Nature Methods 2005 .pdf
Roman Rouzier, Et al. Breast CancerMolecular Subtypes Respond Differently to
Preoperative Chemotherapy
Clinical Cancer Research 2005 .pdf
Britta Weigelt, Et al. Molecular Portraits and 70-Gene Prognosis Signature
Are Preserved throughout the Metastatic Process of Breast Cancer
Cancer Research 2005 .pdf
Chad A Livasy, Et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Modern Pathology 2005 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Tatyana A. Grushko, Et al. MYC Is Amplified in BRCA1-Associated Breast Cancers Clinical Cancer Research 2004 .pdf
Natalia Novoradovskaya, Et al. Universal Reference RNA as a standard for microarray experiments BMC Genomics 2004 .pdf
Christine H. Chung, Et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell 2004 .pdf
Jerry Usary, Et al. Mutation of GATA3 in human breast tumors Oncogene 2004 .pdf
Melissa A. Troester, Et al. Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer Cancer Research 2004 .pdf
Monica Benito, Et al. Adjustment of systematic microarray data biases Bioinformatics 2004 .pdf
Aniko Szabo, Et al. Statistical modeling for selecting housekeeper genes Genome Biology 2004 .pdf
Torsten O. Nielsen, Et al. Immunohistochemical and Clinical Characterization of the Basal-
Like Subtype of Invasive Breast Carcinoma
Clinical Cancer Research 2004 .pdf
Melissa A. Troester, Et al. Prediction of Toxicant-Specific Gene Expression Signatures after
Chemotherapeutic Treatment of Breast Cell Lines
Toxicogenomics 2004 .pdf
J. Michael Thomson, Et al. A custom microarray platform for analysis of microRNA gene expression Nature Methods 2004 .pdf

AUTHOR TITLE JOURNAL YEAR DOWNLOAD
Therese Sørlie, Et al. Repeated observation of breast tumor subtypes in independent gene expression data sets PNAS 2003 .pdf
Charles M Perou Et al. DNA microarrays in breast cancer: the promise of personalised medicine The Lancet 2003 .pdf
Matt van de Rijn, Et al. Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome American Journal of Pathology 2003 .pdf
Michael L. Whitfield, Et al. Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors Molecular Biology of the Cell 2002 .pdf
Jonathan R. Pollack, Et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors PNAS 2002 .pdf
Christine H. Chung, Et al. Molecular portraits and the family tree of cancer Nature Genetics 2002 .pdf
Brian S. Finlin, Et al. RERG Is a Novel ras-related, Estrogen-regulated and Growth-inhibitory Gene in Breast Cancer The Journal of Biological Chemistry 2001 .pdf
Charles M Perou Show me the Data! Nature Genetics 2001 .pdf